Martin H. Huber Jr., President, CEO at Mersana Therapeutics, Inc. (MRSN), sold 2,012 shares at $7.31 ($15K) on 2025-09-12, disclosed to the SEC on 2025-09-15.
Scheduled sale ($15k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MRSN | SELL | 2024-09-13 | $177K | — | Filing → |
| TSRO | SELL | 2018-09-25 | $14K | — | Filing → |
| TSRO | SELL | 2018-03-05 | $198K | — | Filing → |